Common Accuracy Problems in Medication Content

Medication content accuracy problems can hide inside a sentence that sounds entirely reasonable. The grammar works. The reference looks respectable. The missing detail is the one that changes what the reader takes away.

Imagine a draft that says a medicine “works within hours.” An editor asks a small question: works in what sense? A measurable change, a symptom the patient notices, or the outcome the article is discussing?

That question can send the team back to the source. The sentence may need a qualification, a different reference, or removal. A more elegant verb will not settle it.

This is an illustrative editorial scenario, not a patient or client account. The problems below are practical review targets, not a ranked list of the most frequent errors in published content.

1. Treating the medicine’s name as the whole description

A generic name can be a starting point without being a complete description of the product under discussion. Formulation, route, strength, and release characteristics may matter to the statement.

For a product-specific claim, establish which product the source describes before carrying its instructions into an article. A statement about one presentation should not become a statement about every presentation with a similar name.

FDA’s guide to prescription labeling identifies separate sections for dosage and administration, dosage forms and strengths, and use in specific populations.^[1] Those distinctions are useful places to begin a product-level check.

A practical margin note might read: “Confirm the exact formulation and route; this reference appears to describe a different presentation.” That gives the writer a question to resolve rather than a vague request to “check accuracy.”

2. Dropping the population or conditions

“Studied in adults with a defined condition” and “suitable for people with that condition” are different claims. So are an approved indication, an investigational use, and a discussion of practice beyond the approved labeling.

A useful review asks which population the source addresses and whether a restriction disappeared during editing. It also distinguishes what a source reports from what the article recommends.

The correction does not always require a long disclaimer. Sometimes a short qualifying phrase restores the essential boundary. Sometimes the claim itself needs to change.

For the broader review process, see what a pharmacist reviews in medical content.

3. Leaving numbers and units open to interpretation

A medication number needs its meaning attached. Is it a strength, a concentration, an amount per administration, or a quantity over a stated period? Has the denominator survived the edit? Does the figure use the same units as the source?

These are questions to verify against the relevant material, not invitations to calculate or supply missing prescribing instructions from memory.

ISMP identifies abbreviations, symbols, and dose designations associated with harmful or potentially harmful misinterpretation.^[2] Its list is a useful reference when examining medication notation; a familiar abbreviation is not automatically an appropriate one.

For numbers describing outcomes, the reader also needs enough context to understand the comparison and timeframe. CDC’s Clear Communication Index explicitly emphasizes explaining numbers in context.^[3]

A percentage without a clear explanation can look precise while doing very little useful work.

4. Expanding a benefit or shrinking a safety statement

Look for the small words that carry a large claim: “prevents,” “safe,” “always,” “only,” or “no interactions.” Ask what evidence would be needed to support that exact wording.

An observed association should not quietly become proof of causation. A change in a measured endpoint should not become an unqualified promise about a different health outcome. An absence of information in the selected source is not the same thing as evidence that a risk does not exist.

Safety language deserves the same scrutiny as benefit language. FDA’s labeling guide distinguishes contraindications, warnings and precautions, adverse reactions, and interactions.^[1] They should not be flattened into one casual statement that a medicine is either “safe” or “unsafe.”

The editorial job is to preserve the relevant distinction at the level of detail the audience needs.

5. Using a reference without checking its version or purpose

An old reference is not wrong merely because it is old. But a statement about current labeling, an approval, or a current safety recommendation needs a check appropriate to that claim.

Record the product, source version or date, and the location supporting the statement. FDA notes that the Highlights of Prescribing Information are a summary and should not be used alone.^[1] Reading a relevant section in context matters more than collecting an impressive-looking link.

Likewise, an educational overview may be useful for explaining a concept without being the right source for a detailed product instruction. Choose evidence for the job the sentence is doing.

6. Reviewing the paragraph while the graphic tells a different story

A careful body paragraph cannot rescue a headline that overpromises or a diagram that leaves out the qualification. Readers may encounter the graphic first—and may never read the paragraph that explains its limits.

Compare the article’s title, summary, captions, labels, tables, and highlighted boxes with the same evidence used to check the body. Check that “may” has not become “will” in the artwork and that a group result has not been illustrated as a personal guarantee.

For patient-facing material, also ask what someone unfamiliar with the subject is likely to infer. Translating clinical evidence into patient education requires attention to meaning across the whole reading experience.

What a useful accuracy review should leave behind

A long trail of “please check” comments is not much of a handoff. A useful review makes its reasoning visible enough for the team to act.

• Locate the concern: identify the sentence, caption, or figure.
• Explain the mismatch: say what the text implies and what the source supports.
• Point to the evidence: include the relevant section, table, or passage.
• Propose the next step: revise, qualify, replace the reference, or obtain further review.
• Record what remains open: distinguish a resolved edit from a question awaiting evidence or a decision.

Agree on the scope before review starts: supplied-source checking, a broader evidence search, editing, and final proof review are different amounts of work. The guide to writing, editing, and clinical review explains those distinctions.

The objective is not to make every sentence longer. It is to make each important sentence mean what the evidence permits it to mean.

Frequently asked questions

References

1. U.S. Food and Drug Administration. How Do I Use Prescription Drug Labeling.
2. Institute for Safe Medication Practices. List of Error-Prone Abbreviations.
3. Centers for Disease Control and Prevention. Does the Material Always Explain What the Numbers Mean?